| Customization: | Available |
|---|---|
| CAS No: | 147526-32-7 |
| Transport Package: | Bag Drum Box |
|
Still deciding? Get samples of US$ 50/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Product name: Pitavastatin calcium
CAS No: 147526-32-7
Pitavastatin calcium is a crucial lipid - lowering agent that plays a significant role in maintaining cardiovascular health. It has a complex chemical structure that enables it to specifically target and interact with the enzyme 3 - hydroxy - 3 - methylglutaryl - coenzyme A reductase (HMG - CoA reductase). This enzyme is a key regulator in the biosynthesis of cholesterol within the liver. The chemical formula of Pitavastatin calcium is C25H26CaFNO4, which reflects its unique molecular composition.
Application and Effect
Pitavastatin calcium is widely used in the treatment of hyperlipidemia, a condition characterized by elevated levels of lipids in the blood. By specifically targeting the HMG - CoA reductase enzyme, it effectively reduces the production of cholesterol in the liver. This leads to a significant decrease in blood lipid levels, with a particular focus on low - density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol. Lowering LDL cholesterol levels is of utmost importance as it is a major risk factor for cardiovascular diseases. High levels of LDL cholesterol can lead to the formation of plaques within the arteries, a process known as atherosclerosis. These plaques can narrow the arteries and restrict blood flow, increasing the risk of coronary heart disease, stroke, and other cardiovascular complications. By reducing LDL cholesterol levels, Pitavastatin calcium helps to mitigate these risks and improve overall cardiovascular health.
In addition to its effect on LDL cholesterol, Pitavastatin calcium may also have some beneficial effects on other lipid parameters. It can potentially influence triglyceride levels, which are another important component of blood lipids. Additionally, it may have an impact on high - density lipoprotein (HDL) cholesterol, often referred to as "good" cholesterol. While its primary effect is on LDL cholesterol, any positive influence on other lipid parameters further contributes to its overall efficacy in managing hyperlipidemia and cardiovascular health. Overall, Pitavastatin calcium is an essential drug in the management of hyperlipidemia and cardiovascular health. Its ability to target and inhibit the HMG - CoA reductase enzyme, along with its potential effects on other lipid parameters, makes it a valuable tool in reducing the risk of cardiovascular diseases.
Specifications:
| Composition | C25H26CaFNO4 |
| Assay | 99% |
| Appearance | White to off-white solid |
| CAS No. | 147526-32-7 |
| Packing | Small and bulk |
| Shelf Life | 2 years |
| Storage | Store in cool and dry area |
| Certification | ISO. |
){kind=link}